GlassScriptPhysician profile
David J Connito
NPI 1861449704
$929.19
in general payments reported to CMS, 2019-2025
17 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $172 · 2022: $83.91 · 2023: $137 · 2024: $125 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $156.83 | 2019-2020 | |
| Amgen INC. | $125.00 | 2024 | Tavneos |
| Novartis Pharmaceuticals Corporation | $113.88 | 2025 | |
| Bard Peripheral Vascular, INC. | $101.80 | 2019 | |
| Calliditas Therapeutics US INC. | $98.61 | 2023 | Tarpeyo |
| Otsuka America Pharmaceutical, INC. | $72.27 | 2019-2020 | |
| Vifor Pharma, INC. | $41.91 | 2022-2023 | Veltassa |
| Daiichi Sankyo INC. | $36.95 | 2020-2022 | |
| Biomerieux INC | $25.11 | 2019 | |
| Mallinckrodt Enterprises LLC | $24.58 | 2019 | |
| Scpharmaceuticals INC. | $23.77 | 2025 | |
| Mannkind Corporation | $23.77 | 2025 | |
| Baxter Healthcare | $20.32 | 2023 | Renal - Acute |
| Cook Medical LLC | $18.11 | 2025 | Cook |
| Fresenius USA Marketing, INC. | $17.58 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $14.50 | 2022 | |
| Aurinia Pharma U.S., INC. | $14.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Connito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.